Latest News for: geron corporation

Edit

Geron Corporation Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Business Wire 09 Aug 2025
FOSTER CITY, Calif.--(BUSINESS WIRE)--Geron Corporation (Nasdaq ... acceptance of employment with Geron.
Edit

Initial Statement of Beneficial Ownership (Form 3) (Geron Corporation)

Public Technologies 08 Aug 2025
) FORM 3 ... Washington, D.C ... OMB Number. 3235-0104 ... 0.5 ... 2 ... GERON CORP [GERN] ... C/O GERON CORPORATION, 919 E ... 5 ... 5) ... C/O GERON CORPORATION ... Geron Corporation published this content on August 08, 2025, and is solely responsible for the information contained herein.
Edit

Statement of Changes in Beneficial Ownership (Form 4) (Geron Corporation)

Public Technologies 08 Aug 2025
) FORM 4 ... Form 4 or Form 5 obligations may continue ... 0.5 ... GERON CORP [GERN] 5 ... C/O GERON CORPORATION, 919 E ... C/O GERON CORPORATION ... Geron Corporation published this content on August 08, 2025, and is solely responsible for the information contained herein.
Edit

Geron Corporation Reports Second Quarter 2025 Financial Results and Recent Business Highlights

Business Wire 06 Aug 2025
FOSTER CITY, Calif.--(BUSINESS WIRE)--Geron Corporation (Nasdaq.
Edit

Geron Corporation Reports Second Quarter 2025 Financial Results and Recent Business Highlights (Form 8-K) (Geron Corporation)

Public Technologies 06 Aug 2025
) Geron Corporation Reports Second Quarter 2025 Financial Results and Recent Business Highlights ... FOSTER CITY, Calif., August 6, 2025 - Geron Corporation (Nasdaq ... GERON CORPORATION ... Geron Corporation ...
Edit

Initial Registration Statement for Employee Benefit Plan (Form S-8) (Geron Corporation)

Public Technologies 06 Aug 2025
GERON CORPORATION ... Geron Corporation 2018 Inducement Award Plan ... Geron Corporation ... 99.1 Geron Corporation 2018 Inducement Award Plan, as amended ... GERON CORPORATION ... Geron Corporation published this ...
Edit

Management Change/Compensation (Form 8-K) (Geron Corporation)

Public Technologies 06 Aug 2025
On August 1, 2025, the Board of Directors (the "Board") of Geron ... Geron Corporation published this content on August 06, 2025, and is solely responsible for the information contained herein.
Edit

Quarterly Report for Quarter Ending June 30, 2025 (Form 10-Q) (Geron Corporation)

Public Technologies 06 Aug 2025
There are no other royalties payable on RYTELO, which was developed internally and is exclusively owned by Geron ... Geron Corporation published this content on August 06, 2025, and is solely responsible for the information contained herein.
Edit

Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

The Joplin Globe 19 Jul 2025
FOSTER CITY, Calif.--(BUSINESS WIRE)--Jul 18, 2025-- ... .
Edit

Johnson Fistel, PLLP Investigates Claims on Behalf of Long-Term Shareholders of Geron Corporation, Viatris, Everus ...

Nasdaq Globe Newswire 18 Jul 2025
... potential violations of federal and state securities laws by certain officers and directors of Geron Corporation (NASDAQ.
Edit

Outcomes with Imetelstat by Serum Erythropoietin Levels In Patients with Lower-Risk Myelodysplastic Syndromes Who Were Treatment Naive or Who Had Prior Treatment with Erythropoiesis-Stimulating Agents (Geron Corporation)

Public Technologies 14 Jun 2025
Geron Corporation; 2024 ... Geron Corporation; 2025 ... This study was funded by Geron Corporation ... Geron Corporation published this content on June 14, 2025, and is solely responsible for the information contained herein.
Edit

Outcomes of Imetelstat Therapy In Patients with Ring Sideroblast-Negative Lower-Risk Myelodysplastic Syndromes From The Pooled Imerge Study Populations (Geron Corporation)

Public Technologies 14 Jun 2025
Geron Corporation; 2024 ... Geron Corporation; 2025 ... This study was funded by Geron Corporation ... Henriques, PhD, CMPP, of The Lockwood Group (Stamford, CT, USA), funded by Geron Corporation ... Geron ...
Edit

Health-Related Quality of Life Outcomes In Patients with Lower-Risk Myelodysplastic Syndromes Treated with Imetelstat In the Imerge Trial (Geron Corporation)

Public Technologies 14 Jun 2025
Geron Corporation; 2024 ... Geron Corporation; 2025 ... This study was funded by Geron Corporation ... Geron Corporation published this content on June 14, 2025, and is solely responsible for the information contained herein.
Edit

IMpactMF, Randomized, Open-Label, Phase 3 Trial of Imetelstat Versus Best Available Therapy In Patients with Intermediate-2 or High-Risk Myelofibrosis Relapsed or Refractory to Janus Kinase Inhibitors (Geron Corporation)

Public Technologies 13 Jun 2025
Geron Corporation; 2024 ... Geron Corporation; 2025 ... This study was funded by Geron Corporation ... and editorial support were provided by Meredith Rogers, MS, CMPP, of The Lockwood Group (Stamford, CT, USA), funded by Geron Corporation.
Edit

Increased Duration Of Time Without Transfusion Reliance (TWITR) For Patients With Lower-Risk Myelodysplastic Syndromes Treated With Imetelstat Versus Placebo In the Imerge Trial (Geron Corporation)

Public Technologies 13 Jun 2025
Geron Corporation; 2024 ... Geron Corporation; 2025 ... This study was funded by Geron Corporation ... Geron Corporation published this content on June 13, 2025, and is solely responsible for the information contained herein.

Article Search

tools
×
×
×
×